Zdrowie i gospodarka · 28/11/2001

FDA Releases Draft Guidance for Food-Effect Bioavailability and Fed Bioequivalence Studies

The FDA has made available a draft guidance document outlining recommendations for industry sponsors planning to conduct studies on the impact of food on the bioavailability and bioequivalence of certain medications, with the goal of improving the accuracy of labeling and product performance.